Silco Pharmaceuticals Limited (DSE:SILCOPHL)
Bangladesh · Delayed Price · Currency is BDT 13.10
+0.10 (0.77%)
At close: Mar 4, 2026
Silco Pharmaceuticals Market Cap
Silco Pharmaceuticals has a market cap or net worth of 1.36 billion as of March 4, 2026. Its market cap has decreased by -18.13% in one year.
Market Cap
1.36B
Enterprise Value
1.33B
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
13.10
Market Cap Chart
Since June 13, 2019, Silco Pharmaceuticals's market cap has decreased from 2.37B to 1.36B, a decrease of -42.59%. That is a compound annual growth rate of -7.92%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 4, 2026 | 1.36B | -2.96% |
| Dec 30, 2025 | 1.40B | -15.09% |
| Dec 30, 2024 | 1.65B | -32.05% |
| Dec 28, 2023 | 2.43B | - |
| Dec 29, 2022 | 2.43B | -2.90% |
| Dec 30, 2021 | 2.50B | 0.42% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Jun 13, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Asiatic Laboratories | 7.38B |
| Orion Pharma | 7.02B |
| Navana Pharmaceuticals | 6.23B |
| Techno Drugs | 3.89B |
| Ambee Pharmaceuticals | 1.80B |
| Pharma Aids | 1.67B |
| Indo-Bangla Pharmaceuticals | 1.55B |
| Libra Infusions | 1.42B |